Alpha 2.0
Login Register
» Authors » Marina Giuliano

Marina Giuliano

Explore the profile of Marina Giuliano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 678
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Public Health
Top 10 Co-Authors
Mauro Andreotti
Maria Cristina Marazzi
Stefano Vella
Roberta Amici
Leonardo Palombi
Marco Floridia
Sandro Mancinelli
Giuseppe Liotta
Richard Luhanga
Clementina Maria Galluzzo
Published In
J Acquir Immune Defic Syndr
AIDS
AIDS Res Hum Retroviruses
J Antimicrob Chemother
J Med Virol
Affiliations
Soon will be listed here.
Recent Articles
1.
Low levels of pertussis- and measles-specific IgG antibodies in 6-week-old HIV-exposed and -unexposed Malawian infants: implications for vaccination strategies and role of long term HIV therapy
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
J Trop Pediatr . 2025 Mar; 71(2). PMID: 40064194
Serological studies in infants can provide valuable information on the degree of protection conferred by IgG maternal passive transfer during early life. If infant levels are inadequate, protection may be...
2.
Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation
Floridia M, Buonsenso D, Macculi L, Weimer L, Giuliano M, Pricci F, et al.
Children (Basel) . 2025 Jan; 12(1). PMID: 39857859
Background: Few studies have evaluated long-COVID in adolescents. Methods: Cohort study. Demographics, clinical data, and the presence of 30 symptoms were collected with a modified WHO form. Mean values were...
3.
[Analysis of the long-term effects of COVID-19 infection (long-COVID) in Italy during and after the pandemic emergency and response strategy]
Grassi T, Tiple D, Villa M, Grisetti T, Pricci F, Floridia M, et al.
Epidemiol Prev . 2024 Dec; 48(6):438-448. PMID: 39679484
Background: the long-COVID condition is gaining increasing relevance in terms of public health, but few studies have evaluated its impact on use of healthcare resources and the organizational responses of...
4.
Insight into potential long COVID effects: Antidepressant use in post SARS-CoV-2 Infection scenarios. A multiregional nested case-control study
Rosolen V, Beorchia Y, Castriotta L, Fanizza C, Profili F, Floridia M, et al.
Psychiatry Res . 2024 Dec; 344():116290. PMID: 39644590
This study aimed to investigate the impact of previous SARS-CoV-2 infection and the role of vaccination in the onset of neuropsychiatric conditions, evaluated through antidepressant prescriptions. This case-control study evaluated...
5.
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID
Floridia M, Giuliano M, Weimer L, Ciardi M, Agostoni P, Palange P, et al.
BMC Med . 2024 Nov; 22(1):532. PMID: 39543596
Background: Long-COVID symptoms remain incompletely defined due to a large heterogeneity in the populations studied, case definitions, and settings of care. The aim of this study was to assess, in...
6.
Seroprotection against tetanus in HIV-exposed and HIV-unexposed infants in Malawi in 2019-2020
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
BMJ Paediatr Open . 2024 Sep; 8(1). PMID: 39317654
In Malawi, tetanus toxoid vaccination (TTV) is recommended in pregnancy, but few studies have assessed the prevalence of infant seroprotection against tetanus. Anti-TT levels from 84 6-week-old infants, born in...
7.
Examining potential Long COVID effects through utilization of healthcare resources: a retrospective, population-based, matched cohort study comparing individuals with and without prior SARS-CoV-2 infection
Castriotta L, Onder G, Rosolen V, Beorchia Y, Fanizza C, Bellini B, et al.
Eur J Public Health . 2024 Jan; 34(3):592-599. PMID: 38243748
Background: A significant proportion of individuals reports persistent clinical manifestations following SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) acute infection. Nevertheless, knowledge of the burden of this condition-often referred to...
8.
Insufficient measles antibody protection in 6-month-old Malawian infants: Reconsider vaccination schedule?
Baroncelli S, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
Trop Med Int Health . 2023 Aug; 28(9):731-735. PMID: 37533039
Measles vaccination is currently recommended at 9 months, since maternal antibodies are supposed to protect infants until that age. In this study of 6-month-old Malawian infants 98.3% (58/59) had non-protective...
9.
Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants
Baroncelli S, Galluzzo C, Orlando S, Pirillo M, Luhanga R, Mphwere R, et al.
Pathogens . 2023 Jul; 12(7). PMID: 37513785
Background: The evaluation of seroprotection rates against vaccine-preventable infectious diseases allows for the identification of risk populations. HIV-exposed infants, even if not infected with HIV, have higher morbidity and mortality...
10.
Micronutrient and Nutritional Status of HIV-Exposed and HIV-Unexposed Malawian Infants in the First Year of Life: Assessment of Ferritin, Vitamin A, and D Status and Its Association with Growth
Floridia M, Galluzzo C, Orlando S, Luhanga R, Mphwere R, Kavalo T, et al.
Nutrients . 2023 Jul; 15(14). PMID: 37513701
Breastfed Malawian infants from Human Immunodeficiency Virus (HIV)-uninfected and HIV-infected women who received antiretroviral therapy were followed until 12 months of age, allowing us to evaluate plasma levels of ferritin,...